FDA removes safety restrictions on thyroid cancer drug Caprelsa

FDA removes safety restrictions on thyroid cancer drug CaprelsaSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com

FDA removes safety restrictions on thyroid cancer drug CaprelsaSource: Investing.com

Moody’s affirms Mirion’s B1 rating, upgrades senior secured debtSource: Investing.com

Moody’s affirms Tyson Foods’ Baa2 rating, revises outlook to stableSource: Investing.com

US NIH’s $50 million autism initiative grounded in scienceSource: Reuters

OSB Group’s Baa2 rating affirmed by Moody’s, outlook now stableSource: Investing.com

Google, Flo Health to pay $56 million in period-tracking app privacy caseSource: Reuters

India proposes tweaks to foreign investment rules for exports in possible win for AmazonSource: Reuters

Meta to face EU charge for failing to police illegal posts, Bloomberg News reportsSource: Reuters
Corteva stock falls after US launches antitrust probe into crop inputsSource: Investing.com

Brookfield Business Partners stock surges after corporate structure simplificationSource: Investing.com